In the UK,the latest figures published by Diabetes UK(2014)recorded the known population of UK citizens diagnosed with diabetes as 3.2 million,and in 2011,it was estimated that approximately 800,000 people in the UK use injectable therapies to treat their diabetes this figure is likely to have reached a million today
Almost 390 million was spent on injectable therapies for diabetes in 2012-13,around 320 million of which was spent on insulin (health and Social Care Information,2013),so it is imperative that insulin therapy is prescribed in a way that maximizes its therapeutic effect.Therefore,the optimal injection technique